Lancet Infectious Disease has reviewed the epidemiology, causes, clinical features, and current treatment for the multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19, noting severe organ damage can occur pediatric COVID-19 patients who are severely ill.
CDC reports that gmong 3,248 healthcare personnel (HCP) observed, 6% had antibody evidence of previous SARS-CoV-2 infection; 29% of personnel with SARS-CoV-2 antibodies were asymptomatic in the preceding months, and 69% had not previously received a diagnosis of SARS-CoV-2 infection.
Dr. John Cush RheumNow
6 years 1 month ago
Risk of atypical femur fracture increased with longer duration of bisphosphonate (BP) use (HR 8.86 for 3-5yr; HR 43 fo r>8Yr) and rapidly decreased after bisphosphonate discontinuation. HIgher w/ Asians, height, weight, Steroids. https://t.co/I7VT6e031i
Dr. John Cush RheumNow
6 years 1 month ago
President Trump took HCQ/Azithromycin.... Lancet Rheumatology reports that HCQ in RA has no cardiac risk but long term HCQ increases risk cardiovascular mortality, that may be further augmented by azithromycin. https://t.co/JRtkkAuEeu
Dr. John Cush RheumNow
6 years 1 month ago
Non-Radiographic Axial Spondyloarthritis has Its Own Diagnostic Code; As of October 2020, nr-axSpA will be officially included in the 10th version of the International Classification of Diseases (ICD-10) coding manual as M46.8 https://t.co/AftIecd2z3 https://t.co/973yJUW57p
Dr. John Cush RheumNow
6 years 1 month ago
RheumNow Podcast is Up! Rheum Lives Matter. More about social change, HCQ, JAKs & skin, growing cartilage, FM exercise. Watch it here>https://t.co/LLvADsDJ5O or listen to the Podcast here>https://t.co/pCXzaJUS9s
Dr. John Cush RheumNow
6 years 1 month ago
RheumNow Podcast – Rheum Lives Matter (8.28.20)
Dr Jack Cush reviews the news and journal articles from the past week:
https://t.co/pCXzaJUS9s https://t.co/DLmvbzE4um
Dr. John Cush RheumNow
6 years 1 month ago
UK safety reminder that Baricitinib (Olumiant) has an increased risk of diverticulitis (incidence rate 0.16 per 100PY), esp. in those taking Steroids or NSAIDs. https://t.co/IfcV03e1p7
Comorbidities are highly prevalent in psoriatic disease. A recent study in Arthritis Research & Therapy suggests a high prevalence of sleep disturbances, fatigue, and anxiety/depression in psoriatic arthritis (PsA) that is unrelated to skin disease musculoskeletal (MSK) manifestations.
Dr. John Cush RheumNow
6 years 1 month ago
EHR review of acute MSK injuries (13+ million participants) finds prolonged opioid use in high-risk pts (workers' comp, VA pts, substance abuse ) to be 27% but only 6% in low-risk pts; persistent opioid increased w/ older age and physical comorbidity https://t.co/yCDGxpilDT
Dr. John Cush RheumNow
6 years 1 month ago
AbbVie has submited Regulatory Application to FDA and EMA for upadacitinib proposed indication to treate active Ankylosing Spondylitis https://t.co/RPaOXCarEZ
Dr. Jack Cush reviews the news and journal articles from the past week. Of mice and men in cartilage, the efficacy of JAK inhibitors in patients who are having skin problems, nrAxSpa has its own diagnostic code, metformin, talking about Back Talk, plus so much more.
A systematic review of the outcomes of total shoulder replacements (TSR), humeral hemiarthroplasties, and reverse total shoulder replacements finds that approximately 90% of shoulder replacements last for longer than 10 years with good patient-reported outcomes.
Curative direct-acting antiviral therapy (DAAT) for hepatitis-C virus (HCV) infection has been revolutionary, but a novel report shows that nearly one quarter of DAAT treated patients developed new onset or significant worsening of MSK symptoms, despite being negative for hepatitis-C by PCR.

